09 May 2025
// EXPRESSPHARMA
https://www.expresspharma.in/lupin-gains-usfda-nod-for-raltegravir-tablets-usp-600-mg/
07 May 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217990
11 Nov 2024
// EXPRESSPHARMA
https://www.expresspharma.in/lupin-receives-tentative-u-s-fda-approval-for-raltegravir-tablets/
22 Jul 2024
// EUROPEAN PHARMACEUTICAL REVIEW
https://www.europeanpharmaceuticalreview.com/news/231638/generic-hiv-raltegravir-medicines-approved/
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-raltegravir-potassium-tablets-92868.pdf
10 Jul 2019
// Eric Sagonowsky FIERCE PHARMA
https://www.fiercepharma.com/pharma/roche-merck-novartis-and-others-raise-prices-83-meds-to-start-july-analyst?utm_source=internal&utm_medium=rss